Brain metastases can only develop if cancer cells first exit the fine blood vessels and enter into the brain tissue. To facilitate this step, cancer cells influence blood clotting, as Heidelberg scientists from the German ...
Jan 5, 2021
0
13
Michael Green, M.D., Ph.D., noticed that when his patients had cancer that spread to the liver, they fared poorly—more so than when cancer spread to other parts of the body. Not only that, but transformative immunotherapy ...
Jan 4, 2021
0
156
Approximately 200,000 cancer patients are diagnosed with brain metastases each year, yet few treatment options exist because the mechanisms that allow cancer to spread to the brain remain unclear. However, a study recently ...
Dec 8, 2020
0
44
According to an open-access article in ARRS' American Journal of Roentgenology (AJR), fluorine-18-labeled fluciclovine PET/MRI demonstrated utility in the initial staging of high-risk prostate cancer, as well as for evaluating ...
Oct 27, 2020
0
2
Results of a new randomized phase III trial suggest that stereotactic radiosurgery (SRS) should replace whole brain radiation therapy (WBRT) as the standard of care for patients with four or more brain metastases. Compared ...
Oct 26, 2020
0
2
A new intraoperative imaging technique, Cerenkov luminescence imaging (CLI), can accurately assess surgical margins during radical prostatectomy, according to first-in-human research published in the October issue of the ...
Oct 7, 2020
0
1
Though cancer immunotherapy has become a promising standard-of-care treatment—and in some cases, perhaps a cure—for a wide variety of different cancers, it doesn't work for everyone, and researchers have increasingly ...
Oct 2, 2020
0
95
Breast cancer is the most frequent neoplasm among women, impacting 2.1 million women per year. It also has a high risk for intracranial spread. Researchers estimate that up to 30% of all patients with cancer will eventually ...
Sep 28, 2020
0
0
When breast cancer spreads to the brain, the prognosis is grim. Patients only have about six months to live.
Aug 26, 2020
0
210
Patients with non-small cell lung cancer (NSCLC) carrying anaplastic lymphoma kinase (ALK) gene alterations who received ensartinib experienced substantially longer progression-free survival than a matched group of patients ...
Aug 8, 2020
0
2
